Lumora exists because 12 million Americans with treatment-resistant conditions lack sufficient access to advanced interventions. We empower mental health practitioners psychiatrists to overcome financial, operational, and regulatory barriers preventing them from offering life-changing therapies like TMS, Spravato®, ketamine, and wellness infusions.
As a specialized Management Services Organization, we provide:
A non-invasive, FDA-approved treatment for depression and obsessive-compulsive disorder targeting deeper regions in the brain.
An FDA-approved, clinically proven, fast-acting nasal spray for treatment-resistant depression.
Fast relief from depression, anxiety, and more when other treatments don’t work — all under expert medical care.
Each option comes with Lumora protocols, training, and marketing assets.
Chief Executive Officer 30+ Years Healthcare Finance & Law
Chief Financial Officer MSO Operations & Reimbursement Expert
Chief Medical Officer Integrative Psychiatry Pioneer
Chief Branding Officer 30+ Years Marketing & Advertising
APA/FDA-aligned protocols.
Clear 35% MSO fee structure.
AKS/Stark Law-compliant agreements and quarterly compliance.
Insurance navigation and financial assistance.
Partnerships with financial institutions, manufacturers, marketing, advertising, and conversion agencies as well as leading payors.
120-day implementation pathway for new practices.
"*" indicates required fields